Literature DB >> 6175947

Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion.

K Goldberg, F H Wirth, W E Hathaway, M A Guggenheim, J R Murphy, W R Braithwaite, L O Lubchenco.   

Abstract

To determine the effect of partial plasma exchange transfusion, 20 newborn infants with neonatal hyperviscosity were randomly assigned to observation or treatment with partial plasma exchange transfusion within the first eight hours after birth. They were studied for organ involvement by roentgenogram, blood count, coagulation studies, and neurologic behavior and were followed up using the Brazelton Neonatal Behavior Assessment scale at 8, 24, and 72 hours and 2 weeks of age; in addition, ten control infants without hyperviscosity of similar birth weights and gestational ages were also studied. Exchange transfusion improved blood viscosity but both hyperviscous groups showed a higher proportion of abnormal results than did the control subjects. Infants receiving exchange transfusions subsequently improved during the period from 8 hours to 2 to 3 weeks of age, until they were indistinguishable from the control subjects. Neurologic improvement in hyperviscous infants who had not received exchange transfusions were significantly slower during this period. At 8 months of age, abnormal neurologic and developmental findings were impressive in both groups; no significant differences in neurologic abnormalities were noted at that time. Developmental delays, tremors, spastic diplegia, and monoparesis were found in four of six untreated infants and five of ten infants who had received exchange transfusions. A fine tremor was present in one control child.

Entities:  

Mesh:

Year:  1982        PMID: 6175947

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

Review 1.  Neonatal polycythemia--issues and current perspectives.

Authors:  S Singh; A Narang; S Gulati
Journal:  Indian J Pediatr       Date:  1990 Sep-Oct       Impact factor: 1.967

2.  Management of polycythemia in neonates.

Authors:  M Jeeva Sankar; Ramesh Agarwal; Ashok Deorari; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2010-08-21       Impact factor: 1.967

Review 3.  Short and long term outcomes following partial exchange transfusion in the polycythaemic newborn: a systematic review.

Authors:  E M Dempsey; K Barrington
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-09-20       Impact factor: 5.747

4.  Neonatal polycythemia.

Authors:  L Krishnan; A Rahim
Journal:  Indian J Pediatr       Date:  1997 Jul-Aug       Impact factor: 1.967

5.  Effects of partial plasma exchange transfusion on cerebral blood flow velocity in polycythaemic preterm, term and small for date newborn infants.

Authors:  W J Maertzdorf; G J Tangelder; D W Slaaf; C E Blanco
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

6.  Hyperviscosity in the newborn: the scope of the problem.

Authors:  M H LeBlanc; K Pate
Journal:  Bull N Y Acad Med       Date:  1986-05

7.  Randomised controlled trial: comparison of colloid or crystalloid for partial exchange transfusion for treatment of neonatal polycythaemia.

Authors:  W Wong; T F Fok; C H Lee; P C Ng; K W So; Y Ou; K L Cheung
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

Review 8.  Polycythemia in the newborn.

Authors:  Amit Upadhyay; Rajiv Aggarwal; Ashok K Deorari; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2002-01       Impact factor: 1.967

Review 9.  Polycythemia in the newborn.

Authors:  M Jeevasankar; Ramesh Agarwal; Deepak Chawla; Vinod K Paul; Ashok K Deorari
Journal:  Indian J Pediatr       Date:  2008-01       Impact factor: 1.967

10.  Polycythemia in neonatal intensive care unit, risk factors, symptoms, pattern, and management controversy.

Authors:  Tariq Rushdi Mohieldeen Alsafadi; Saad Manzoor Hashmi; Hala Atta Youssef; Awatif Khogali Suliman; Haifa'A Mansour Abbas; Mohammad Hakem Albaloushi
Journal:  J Clin Neonatol       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.